Research output: Contribution to journal › Article › Academic › peer-review
Injection drug use and hepatitis C virus infection in young adult injectors: using evidence to inform comprehensive prevention. / Page, Kimberly; Morris, Meghan D.; Hahn, Judith A. et al.
In: Clinical infectious diseases, Vol. 57, No. Suppl. 2, 2013, p. S32-S38.Research output: Contribution to journal › Article › Academic › peer-review
}
TY - JOUR
T1 - Injection drug use and hepatitis C virus infection in young adult injectors: using evidence to inform comprehensive prevention
AU - Page, Kimberly
AU - Morris, Meghan D.
AU - Hahn, Judith A.
AU - Maher, Lisa
AU - Prins, Maria
PY - 2013
Y1 - 2013
N2 - The hepatitis C virus (HCV) virus epidemic is ongoing in the United States and globally. Incidence rates remain high, especially in young adult injection drug users. New outbreaks of HCV in the United States among young adults, in predominantly suburban and rural areas, have emerged and may be fueling an increase in HCV. This paper discusses some key HCV prevention strategies that to date have not been widely researched or implemented, and wherein future HCV prevention efforts may be focused: (1) reducing sharing of drug preparation equipment; (2) HCV screening, and testing and counseling; (3) risk reduction within injecting relationships; (4) injection cessation and "breaks"; (5) scaled-up needle/syringe distribution, HCV treatment, and vaccines, according to suggestions from mathematical models; and (6) "combination prevention." With ongoing and expanding transmission of HCV, there is little doubt that there is a need for implementing what is in the prevention "toolbox" as well as adding to it. Strong advocacy and resources are needed to overcome challenges to providing the multiple and comprehensive programs that could reduce HCV transmission and associated burden of disease worldwide in people who inject drugs
AB - The hepatitis C virus (HCV) virus epidemic is ongoing in the United States and globally. Incidence rates remain high, especially in young adult injection drug users. New outbreaks of HCV in the United States among young adults, in predominantly suburban and rural areas, have emerged and may be fueling an increase in HCV. This paper discusses some key HCV prevention strategies that to date have not been widely researched or implemented, and wherein future HCV prevention efforts may be focused: (1) reducing sharing of drug preparation equipment; (2) HCV screening, and testing and counseling; (3) risk reduction within injecting relationships; (4) injection cessation and "breaks"; (5) scaled-up needle/syringe distribution, HCV treatment, and vaccines, according to suggestions from mathematical models; and (6) "combination prevention." With ongoing and expanding transmission of HCV, there is little doubt that there is a need for implementing what is in the prevention "toolbox" as well as adding to it. Strong advocacy and resources are needed to overcome challenges to providing the multiple and comprehensive programs that could reduce HCV transmission and associated burden of disease worldwide in people who inject drugs
U2 - 10.1093/cid/cit300
DO - 10.1093/cid/cit300
M3 - Article
C2 - 23884063
VL - 57
SP - S32-S38
JO - Clinical infectious diseases
JF - Clinical infectious diseases
SN - 1058-4838
IS - Suppl. 2
ER -
ID: 2186181